BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21439246)

  • 1. Tumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with glioma.
    Cogdell D; Chung W; Liu Y; McDonald JM; Aldape K; Issa JP; Fuller GN; Zhang W
    Chin J Cancer; 2011 Apr; 30(4):247-53. PubMed ID: 21439246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherens junctions associated protein 1 serves as a predictor of recurrence of squamous cell carcinoma of the esophagus.
    Tanaka H; Kanda M; Koike M; Iwata N; Shimizu D; Ezaka K; Sueoka S; Tanaka Y; Takami H; Hashimoto R; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
    Int J Oncol; 2015 Nov; 47(5):1811-8. PubMed ID: 26397940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.
    Hong C; Maunakea A; Jun P; Bollen AW; Hodgson JG; Goldenberg DD; Weiss WA; Costello JF
    Cancer Res; 2005 May; 65(9):3617-23. PubMed ID: 15867356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SHREW1 gene, frequently deleted in oligodendrogliomas, functions to inhibit cell adhesion and migration.
    McDonald JM; Dunlap S; Cogdell D; Dunmire V; Wei Q; Starzinski-Powitz A; Sawaya R; Bruner J; Fuller GN; Aldape K; Zhang W
    Cancer Biol Ther; 2006 Mar; 5(3):300-4. PubMed ID: 16410724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced Expression of Adherens Junctions Associated Protein 1 Predicts Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.
    Ezaka K; Kanda M; Sugimoto H; Shimizu D; Oya H; Nomoto S; Sueoka S; Tanaka Y; Takami H; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1499-507. PubMed ID: 26122373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LOH 19q indicates shorter disease progression-free interval in low-grade oligodendrogliomas with EMP3 methylation.
    Pasini A; Iorio P; Bianchi E; Cerasoli S; Cremonini AM; Faedi M; Guarnieri C; Guiducci G; Riccioni L; Molinari C; Rengucci C; Calistri D; Giordano E
    Oncol Rep; 2012 Dec; 28(6):2271-7. PubMed ID: 22992787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion or epigenetic silencing of AJAP1 on 1p36 in glioblastoma.
    Lin N; Di C; Bortoff K; Fu J; Truszkowski P; Killela P; Duncan C; McLendon R; Bigner D; Gregory S; Adamson DC
    Mol Cancer Res; 2012 Feb; 10(2):208-17. PubMed ID: 22241217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherens junctional associated protein-1: a novel 1p36 tumor suppressor candidate in gliomas (Review).
    Zeng L; Fee BE; Rivas MV; Lin J; Adamson DC
    Int J Oncol; 2014 Jul; 45(1):13-7. PubMed ID: 24807315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas.
    Yi L; Fan X; Li J; Yuan F; Zhao J; Nistér M; Yang X
    Aging (Albany NY); 2021 Jan; 13(3):3645-3660. PubMed ID: 33493139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.
    Möllemann M; Wolter M; Felsberg J; Collins VP; Reifenberger G
    Int J Cancer; 2005 Jan; 113(3):379-85. PubMed ID: 15455350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant hypermethylation of non-promoter zygote arrest 1 (ZAR1) in human brain tumors.
    Watanabe T; Yachi K; Ohta T; Fukushima T; Yoshino A; Katayama Y; Shinojima Y; Terui T; Nagase H
    Neurol Med Chir (Tokyo); 2010; 50(12):1062-9. PubMed ID: 21206179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR/EGFRvIII remodels the cytoskeleton via epigenetic silencing of AJAP1 in glioma cells.
    Yang C; Li YS; Wang QX; Huang K; Wei JW; Wang YF; Zhou JH; Yi KK; Zhang KL; Zhou BC; Liu C; Zeng L; Kang CS
    Cancer Lett; 2017 Sep; 403():119-127. PubMed ID: 28634045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AJAP1 expression modulates glioma cell motility and correlates with tumor growth and survival.
    Di C; Mladkova N; Lin J; Fee B; Rivas M; Chunsheng K; Bigner D; Adamson DC
    Int J Oncol; 2018 Jan; 52(1):47-54. PubMed ID: 29115565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of the p73 gene in gliomas.
    Watanabe T; Huang H; Nakamura M; Wischhusen J; Weller M; Kleihues P; Ohgaki H
    Acta Neuropathol; 2002 Oct; 104(4):357-62. PubMed ID: 12200621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation in the promoter region inhibits AJAP1 expression and activates the JAK/STAT pathway to promote prostate cancer cell migration and stem cell sphere formation.
    Chen L; Wang Y; Zhang B
    Pathol Res Pract; 2023 Jan; 241():154224. PubMed ID: 36566599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct methylation profiles of glioma subtypes.
    Uhlmann K; Rohde K; Zeller C; Szymas J; Vogel S; Marczinek K; Thiel G; Nürnberg P; Laird PW
    Int J Cancer; 2003 Aug; 106(1):52-9. PubMed ID: 12794756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.
    van den Bent MJ; Dubbink HJ; Sanson M; van der Lee-Haarloo CR; Hegi M; Jeuken JW; Ibdaih A; Brandes AA; Taphoorn MJ; Frenay M; Lacombe D; Gorlia T; Dinjens WN; Kros JM
    J Clin Oncol; 2009 Dec; 27(35):5881-6. PubMed ID: 19901104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent epigenetic inactivation of the SLIT2 gene in gliomas.
    Dallol A; Krex D; Hesson L; Eng C; Maher ER; Latif F
    Oncogene; 2003 Jul; 22(29):4611-6. PubMed ID: 12881718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AJAP1 is dysregulated at an early stage of gliomagenesis and suppresses invasion through cytoskeleton reorganization.
    Han L; Zhang KL; Zhang JX; Zeng L; Di CH; Fee BE; Rivas M; Bao ZS; Jiang T; Bigner D; Kang CS; Adamson DC
    CNS Neurosci Ther; 2014 May; 20(5):429-37. PubMed ID: 24483339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.